Abbreviations


Solid Lipid Based Nano-particulate Formulations in Drug Targeting DOI: http://dx.doi.org/10.5772/intechopen.88268

employed for delivering not only the drug but also antibody, proteins, genes, imaging agents etc. and bring about increased cellular uptake at the targeted disease sites. Moreover, surface modification of SLNs through conjugation of various ligands on SLNs surfaces helped in enhancing its targeting efficacy in terms of cellular binding, uptake and intracellular transport to different cells as well as organs and ensure its greatest potentiality to combat wide ranges of diseases. However, the intrinsic complexity of biological environments strongly influences its functionality and often complicates their effective use for therapeutic treatments. Therefore, a deeper knowledge and understanding of the real interactions involved in the diseased tissues

is fundamental for the development of therapeutic protocols of SLNs.

The authors confirm that this article content has no conflicts of interest.

ANGPTL2 RNA single-stranded proline-modified short hairpin antiangiopoietin-like protein 2

Conflict of interest

AM alveolar macrophages

Role of Novel Drug Delivery Vehicles in Nanobiomedicine

BH betaxolol hydrochloride

CIR-780 cyanine-type IR-780 CMP camptothecin CO cholesterol oleate COMP compritol 888 ATO CP cetyl palmitate CRM carmustine c-SLN cationic SLN CSPT cisplatin

Cs-SLN chitosan coated SLNs

DMPC 1,2-dimyristoyl-sn-glycero-3-phospho-choline

(polyethylene glycol)-2000] DSGPC 1,2-distearoyl-sn-glycero-3-phosphocholine

FA-PEG-SLN folic acid-polyethylene glycol cross conjugated SLN

DSPEG 1,2-distearoyl-snglycero-3-phosphoethanolamine-N-[carboxy

DSPE Distearoylphosphatidyl-ethanolamine

AP-E apolipoprotein E ASGP asialoglycoprotein

BAI baicalein BBR berberine BCL baicalin

CHO cholesterol

CUR curcumin CurB curcumin B DM dimyristoyl

DTX docetaxel DXM dexamethasone

116

FB Ficus benjamina FR folate receptor

F-SLN fucose conjugated SLN Ft-SLN folate conjugated SLN GB glyceryl behenate

Abbreviations


References

[1] Himri I, Guaadaoui A. Cell and organ drug targeting: Types of drug delivery systems and advanced targeting strategies. In: Grumezescu AM, editor. Nanostructures for the Engineering of Cells, Tissues and Organs: From Design

DOI: http://dx.doi.org/10.5772/intechopen.88268

Solid Lipid Based Nano-particulate Formulations in Drug Targeting

Therapeutics. Rijeka, Croatia: IntechOpen; 2016. pp. 1-13. DOI:

[8] Rostami E, Kashanian S, Azandaryani AH, Faramarzi H, Dolatabadi JEN, Omidfar K. Drug targeting using solid lipid nanoparticles. Chemistry and Physics of Lipids. 2014; 181:56-61. DOI: 10.1016/j.chemphyslip.

[9] Deshpande A, Mohamed M, Daftardar SM, Patel M, Boddu SHS, Nesamony J. Solid lipid nanoparticles in drug delivery: Opportunities and challenges. In: Mitra A, Cholkar K, Mandal A, editors. Emerging

Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices Micro and

[10] Dhanasekaran S, Chopra S. Getting a handle on smart drug delivery systems—A comprehensive view of therapeutic targeting strategies. In: Sezer AD, editor. Smart Drug Delivery System. Rijeka, Croatia: IntechOpen; 2015. pp. 31-62. DOI:

[11] Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. International Journal of Nanomedicine. 2009;4:299-319. DOI: 10.2147/IJN.S4937

insulin. International Journal of

[12] Liu J, Gong T, Fu H, et al. Solid lipid nanoparticles for pulmonary delivery of

Pharmaceutics. 2008;356(1–2):333-344. DOI: 10.1016/j.ijpharm.2008.01.008

[13] Bi R, Shao W, Wang Q, Zhang N. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. Journal of Biomedical Nanotechnology. 2009;5: 84-92. DOI: 10.1166/jbn.2009.036

Nano Technologies. Amsterdam, Netherlands: Elsevier; 2017. pp. 291-330. DOI: 10.1016/B978-0-

323-42978-8.00012-7

10.5772/61388

10.5772/65245

2014.03.006

to Applications. Oxford, United Kingdom: Willium Andrew Applied Science Publisher (an imprint of Elsevier); 2018. pp. 1-66. DOI: 10.1016/

B978-0-12-813665-2.00001-6

based targeted drug delivery.

1097-8542.757275

yexmp.2008.12.004

[5] Palei NP, Mohanta BC,

Organic Materials as Smart

Sabapathi ML, Das MK. Lipid-based nanoparticles for cancer diagnosis and therapy. In: Grumezescu AM, editor.

Nanocarriers for Drug Delivery. Oxford, United Kingdom: Willium Andrew Applied Science Publisher (an imprint of Elsevier); 2018. pp. 415-470. DOI: 10.1016/B978-0-12-813663-8.00010-5

[6] Sharma J, Kalra S, Sharma A, Rani S. Colloidal drug carriers. The Internet Journal of Family Practice. 2009;

[7] Maiti S, Sen KK. Drug delivery concepts. In: Maiti S, Sen KK, editors. Advanced Technology for Delivering

1000112

9(2):1-6

119

[2] Saltzman WM, Torchilin VP. Drug delivery systems. In: Access Science. 16th ed. Chicago: McGraw-Hill Education; 2016. DOI: 10.1036/

[3] Singh R, Willard JJW. Nanoparticle-

Experimental and Molecular Pathology. 2009;86:215-223. DOI: 10.1016/j.

[4] Bibhas CM, Subas CD, Gitanjali M, Narahari NP. Exploring the use of lipid based nano-formulations for the management of tuberculosis. Journal of Nanosciences: Current Research. 2017; 2(3):1-15. DOI: 10.4172/2572-0813.
